Facebook
Instagram
Linkedin
Twitter
Vimeo
Home
Single Company Reports
Investment Trust Centre
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
- Advertisement -
Andrew Hore
twitter
Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.
IPO Analysis
New standard listing: Oxford Nanopore Technologies
Premium
FRC investigates audit of former AIM company subsidiary
Premium
Elliott Bernerd identifies value in Fletcher King
IPO Analysis
New standard listing: David Williams launches shell Bay Capital
IPO Analysis
New AIM admission: Made Tech’s digital potential
IPO Analysis
New AIM admission: Peel Hunt floats after profit peaks
Premium
LoopUp cash call at large discount
IPO Analysis
New AIM admission: GreenRoc Mining’s battery-powered prospects
Premium
Tip update: Transense progressing to profit
Premium
Exscientia set to propel Frontier IP NAV
Premium
Tip update: Holland deal opens up market for Maestrano
Premium
Demand recovers for Medica radiology services
IPO Analysis
New standard listing: Alkemy Capital seeks technology metals buy
Premium
Parity invests for recovery
Premium
Director Dealings: Parsley Box at a discount
Premium
More to SourceBio International than Covid-19 testing
Premium
Director dealings: Eleco bosses buy after strategy update
IPO Analysis
Marley on course for premium listing
Premium
Duke Royalty starts to invest cash pile
Premium
Semafone luanches lawsuit against PCI-Pal
Premium
Equals set for jump in profit
IPO Analysis
New Aquis admission: VSA Capital betting on Aquis
Premium
Buoyant US demand trebles Somero profit
Premium
Tip update: Long-term prospects still huge for Destiny Pharma
Premium
Alumasc surges ahead
Premium
Belvoir continues to prosper
Premium
PCI-Pal’s international growth plans
Premium
Special prospects for Dunelm
Premium
Churchill China proves its resilience
AQUIS
VSA Capital returns to the market in London
Load more
Xpeng – the Tesla rival whose shares have rallied 315% in two months
23/11/2020
‘End of Austerity’ promise hashed out during PMQs
10/10/2018
Brexit: 5,000 City jobs could leave UK
10/10/2018
Advanced Oncotherapy shares soar after cancer treatment milestone
10/10/2018
Two reasons Travelodge backers can expect sleepless nights
24/07/2020